T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,270.00
-55.00 (-1.27%)
Mar 28, 2025, 3:30 PM KST
-55.29%
Market Cap 92.00B
Revenue (ttm) 5.08B
Net Income (ttm) -13.74B
Shares Out 21.55M
EPS (ttm) -640.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 91,876
Average Volume 209,002
Open 4,280.00
Previous Close 4,325.00
Day's Range 4,020.00 - 4,280.00
52-Week Range 2,840.00 - 9,230.00
Beta 0.83
RSI 59.34
Earnings Date Mar 17, 2025

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

In 2023, T&R Biofab's revenue was 5.20 billion, a decrease of -9.65% compared to the previous year's 5.75 billion. Losses were -13.42 billion, 29.8% more than in 2022.

Financial Statements

News

There is no news available yet.